We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

26 hedge funds and large institutions have $7.22M invested in Ocera Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

28% less funds holding

Funds holding: 36 → 26 (-10)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

62% less capital invested

Capital invested by funds: $19.2M → $7.22M (-$12M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
26
Holders Change
-10
Holders Change %
-27.78%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
10
Reduced
2
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$2.74M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.15M
3
HP
Hikari Power
Japan
+$318K
4
BlackRock
BlackRock
New York
+$79.4K
5
Citadel Advisors
Citadel Advisors
Florida
+$70.9K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$4.12M
2
IVM
InterWest Venture Management
California
-$2.62M
3
QF
QVT Financial
New York
-$1.9M
4
DM
Deerfield Management
New York
-$1.2M
5
SM
Sabby Management
Florida
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPP
26
Great Point Partners
Connecticut
– -$4.12M -1,963,777 Closed
IVM
27
InterWest Venture Management
California
– -$2.62M -1,248,064 Closed
QF
28
QVT Financial
New York
– -$1.9M -906,286 Closed
DM
29
Deerfield Management
New York
– -$1.2M -572,893 Closed
SM
30
Sabby Management
Florida
– -$690K -328,632 Closed
Millennium Management
31
Millennium Management
New York
– -$672K -320,000 Closed
PVI
32
Pura Vida Investments
New York
– -$544K -258,893 Closed
Renaissance Technologies
33
Renaissance Technologies
New York
– -$460K -219,100 Closed
VC
34
Vivo Capital
California
– -$322K -153,331 Closed
WMSA
35
Weiss Multi-Strategy Advisers
New York
– -$231K -110,000 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$73K -34,751 Closed
Goldman Sachs
37
Goldman Sachs
New York
– -$42K -20,193 Closed
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
– -$33K -15,648 Closed
Creative Planning
39
Creative Planning
Kansas
– -$3K -1,500 Closed
AIM
40
Acrospire Investment Management
Illinois
– -$1K -700 Closed
Deutsche Bank
41
Deutsche Bank
Germany
– +$255 +200 New
1
2

OCRX Hedge Fund Activity: Q1 2017 in Review

26 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q1 2017, worth a combined $7.22M — down 62% from $19.2M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OCRX and 9 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 10 added.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.74M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.12M sold.

  • 26 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q1 2017, down from 36 in Q4 2016.
  • Funds reported $7.22M of Ocera Therapeutics, Inc. stock for Q1 2017, down 62% quarter-over-quarter.
  • 9 funds opened new Ocera Therapeutics, Inc. positions in Q1 2017 and 16 closed out, a net change of -7 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q1 2017 was Perceptive Advisors, an estimated $2.74M added.
  • The largest Ocera Therapeutics, Inc. seller in Q1 2017 was Great Point Partners, an estimated $4.12M sold.

Based on aggregated 13F filings for Q1 2017.